CSIMarket
 


Allogene Therapeutics inc   (ALLO)
Other Ticker:  
 

Allogene Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Allogene Therapeutics Inc in the forth quarter 2023?
Allogene Therapeutics Inc recorded a cumulative net loss of $-327 million during 12 months ending in the forth quarter 2023, resulting in a negative return on equity (ROE) of -56.66%.

Within the Biotechnology & Pharmaceuticals industry 92 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2023 from 1322 to 3744.

What is ROE?



Return On Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -23.19 % -21.2 % -22.33 % -30.75 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -327 -341 -362 -359 -340
Return On Equity (TTM) -56.66 % -55.27 % -55.3 % -51.3 % -44.44 %
ALLO's Total Ranking # 3744 # 1322 # 937 # 3187 # 3312
Equity (TTM) in Millions 512 583 623 592 667
Seq. Equity Change -12.15 % -6.39 % 5.17 % -11.19 % -9.88 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 93
Sector # 594
Overall # 3744

Return On Equity Statistics
High Average Low
-12.04 %
-33.12 %
-56.66 %
(Sep 30 2019)   (Dec 31 2023)





ALLO Annual Return On Equity (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Equity in Millions 512 667 916 1,080 629
Y / Y Equity Change -23.19 % -27.23 % -15.12 % 71.63 % -10.54 %
Net Income in Millions -327 -340 -257 -250 -185
Y / Y Net Income Change - - - - -
Return On Equity -63.89 % -51.05 % -28.04 % -23.18 % -29.35 %





More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ALLO's' Return on Equity at Yahoo Finance
ALLO's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for ALLO's Competitors
Return On Equity for Allogene Therapeutics Inc 's Suppliers
Roe for ALLO's Customers




Companies with similar Return On Equity at Dec 31 2023, within Healthcare Sector ROE


Date modified: 2024-03-15T05:36:26+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com